Ferritin levels in the cerebrospinal fluid predict Alzheimer’s disease outcomes and are regulated by APOE
Scott Ayton(Florey Institute of Neuroscience and Mental Health), Norm Foster(University of Utah), Danielle Harvey(UC San Diego Health System), Nick C. Fox(NIHR Queen Square Dementia Biomedical Research Unit), Gus Jiminez(UC San Diego Health System), John Q. Trojanowki(University of Southern California), Andrew J. Saykin(Alzheimer’s Disease Neuroimaging Initiative), Tamie Sather(University of California San Diego), Michael Donohue(Alzheimer’s Disease Neuroimaging Initiative), Tom Montine(University of Washington), Howard Fillit(Alzheimer's Drug Discovery Foundation), Ashley I. Bush(Florey Institute of Neuroscience and Mental Health), Ronald G. Thomas(UC San Diego Health System), Adam J. Schwartz(Eli Lilly (United States)), Prashanthi Vemuri(Mayo Clinic in Arizona), Norbert Schuff(University of California, Davis), Ronald C. Petersen(Mayo Clinic in Arizona), Sarah Walter(UC San Diego Health System), Matthew L. Senjem(Mayo Clinic in Florida), Bret Borowski(Mayo Clinic in Florida), Franz Hefti(Washington University in St. Louis), Laurel Beckett(Brigham and Women's Hospital), Noel G. Faux(Mental Health Research Institute), John C. Morris(Washington University in St. Louis), Davie Holtzman(Northwestern University), Kejal Kantarci(Mayo Clinic in Arizona), Greg Sorensen(Alzheimer's Association), Peter J. Davies(Texas A&M Health Science Center), Robert A. Koeppe(University of Michigan), Matt A. Bernstein(University of London), Peter J. Snyder(University of Connecticut), Zaven S. Khachaturian(University of Southern California), Paul M. Thompson(University of Southern California), Leslie M. Shaw(California University of Pennsylvania), Robert C. Green(Boston University), Michael W. Weiner(University of California, San Francisco), David Jones(Mayo Clinic in Arizona), William Z. Potter(United States Military Academy), William Jagust(Lawrence Berkeley National Laboratory), Devon Gessert(UC San Diego Health System), Paul Aisen(University of Southern California), Marek-Marsel Mesulam(Northwestern University), Steven M. Paul(Baker Engineering (United States)), Marc Raichle(Washington University in St. Louis), Chad Ward(University of Michigan), Lew Kuller(Washington University in St. Louis), Clifford R. Jack(Mayo Clinic), Jeff Gunter(Mayo Clinic in Florida), Arthur W. Toga(University of California, Los Angeles)
Cited by 325
Related Papers
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|18.9k
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Mild cognitive impairment as a diagnostic entity
|Journal of Internal Medicine|2004|7.8k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k